<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74877</article-id><article-id pub-id-type="doi">10.7554/eLife.74877</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-258301"><name><surname>Afsar</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258302"><name><surname>Narayan</surname><given-names>Rohan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258303"><name><surname>Akhtar</surname><given-names>Md Noor</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4669-1543</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272160"><name><surname>Das</surname><given-names>Deepakash</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258296"><name><surname>Rahil</surname><given-names>Huma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272161"><name><surname>Nagaraj</surname><given-names>Santhosh Kambaiah</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-116121"><name><surname>Eswarappa</surname><given-names>Sandeep M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7903-5198</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258304"><name><surname>Tripathi</surname><given-names>Shashank</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-116688"><name><surname>Hussain</surname><given-names>Tanweer</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4735-2380</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular Reproduction, Development and Genetics</institution>, <institution>Indian Institute of Science Bangalore</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff2"><institution content-type="dept">Department of Microbiology and Cell Biology</institution>, <institution>Indian Institute of Science Bangalore</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry</institution>, <institution>Indian Institute of Science Bangalore</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff4"><institution content-type="dept">BiochemistryDepartment of Biochemistry</institution>, <institution>Indian Institute of Science Bangalore</institution>, <addr-line><named-content content-type="city">Bengaluru</named-content></addr-line>, <country>India</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-105903"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><role>Reviewing editor</role><aff><institution>University College London</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hussain@iisc.ac.in</email> (TH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74877</elocation-id><history><date date-type="received"><day>20</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>23</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Afsar et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Afsar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74877-v1.pdf"/><abstract><p>The SARS-CoV-2 non-structural protein 1 (Nsp1) contains an N-terminal domain and C-terminal helices connected by a short linker region. The C-terminal helices of Nsp1 (Nsp1-C-ter) from SARS-CoV-2 bind in the mRNA entry channel of the 40S ribosomal subunit and blocks mRNA entry, thereby shutting down host protein synthesis. Nsp1 suppresses host immune function and is vital for viral replication. Hence, Nsp1 appears to be an attractive target for therapeutics. In this study, we have <italic>in silico</italic> screened Food and Drug Administration (FDA)-approved drugs against Nsp1-C-ter. Among the top hits obtained, montelukast sodium hydrate binds to Nsp1 with a binding affinity (K<sub>D</sub>) of 10.8±0.2 µM <italic>in vitro</italic>. It forms a stable complex with Nsp1-C-ter in simulation runs with -95.8±13.3 kJ/mol binding energy. Montelukast sodium hydrate also rescues the inhibitory effect of Nsp1 in host protein synthesis, as demonstrated by the expression of firefly luciferase reporter gene in cells. Importantly, it shows antiviral activity against SARS-CoV-2 with reduced viral replication in HEK cells expressing ACE2 and Vero-E6 cells. We, therefore, propose montelukast sodium hydrate can be used as a lead molecule to design potent inhibitors to help combat SARS-CoV-2 infection.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>DBT-Wellcome Trust India Alliance</institution></institution-wrap></funding-source><award-id>IA/I/17/2/503313</award-id><principal-award-recipient><name><surname>Hussain</surname><given-names>Tanweer</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>IRPHA</institution></institution-wrap></funding-source><award-id>IPA/2020/000094</award-id><principal-award-recipient><name><surname>Hussain</surname><given-names>Tanweer</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>DBT-Wellcome Trust India Alliance</institution></institution-wrap></funding-source><award-id>IA/I/18/1/503613</award-id><principal-award-recipient><name><surname>Tripathi</surname><given-names>Shashank</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Swarnajayanti Fellowship</institution></institution-wrap></funding-source><award-id>SB/SJF/2020-21/18</award-id><principal-award-recipient><name><surname>Eswarappa</surname><given-names>Sandeep M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file.</p></sec><supplementary-material><ext-link xlink:href="elife-74877-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>